Developing A Quantitative Systems Pharmacology (QSP) Disease Progression Model To Inform Clinical Trial Target Values in Cachexia | Kisaco Research

Developing A Quantitative Systems Pharmacology (QSP) Disease Progression Model To Inform Clinical Trial Target Values in Cachexia

  • Highlighting the challenges for clinical trial design in areas where robust clinical trial data is lacking
  • Leveraging real-world data (RWD) to inform QSP disease progression models
  • Demonstrating how the QSP-RWD modeling framework was used to establish a target value for early go/no-go decision making
Speaker(s): 

Author:

Lyndsey Meyer

Principal Scientist
Pfizer
... read more

Lyndsey Meyer

Principal Scientist
Pfizer